ABAT and epilepsy: Silverman has designed and evaluated a variety of GABA analogues as GABA-AT inhibitors [29,30,31,32], including CP-115, a compound 186 times more efficient in inactivating GABA-AT than VGB and with a high therapeutic potential for the treatment of epilepsies and cocaine addiction [33].